- This event has passed.
Depression, Suicide, and Ketamine Usage
September 12, 2018, 8:00 pm - 9:30 pm
Presenter: Howard Wishnie, M.D.
Ketamine, initially used as a veterinary anesthetic, has become a medication used in human cases of refractory depression. While some training programs are setting up clinical research programs, a number of physicians have established clinical practices using Ketamine. This presentation will focus upon Ketamine’s effect on CNS neurotransmitters and brain centers that seem involved with depression, as well as the need for psychological integration of the Ketamine experience.
Greenberg, R. (2018). Suicide Deaths Climb Dramatically in U.S., Nearly Double for Women. Psychiatric News, 53(13).
Tasman, A. (2018). The wrong way on a Long and winding Road: Suicide in the U.S. Psychiatric Times, XXXV(2).
Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Medicated Frontoparietal Connectivity in Humans. J Neuroscience, 35(33).